The Revenue for the quarter ended  June 2024 of Rs. 128.89 millions grew by 21.81 % from Rs. 105.81 millions.The Net Loss for the quarter ended June 2024 is Rs. -51.71 millions as compared to Net Loss of Rs. -53.32 millions of corresponding quarter ended June 2023 Operating profit Margin for the quarter ended June 2024 improved to -21.63% as compared to -25.82% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 128.89 105.81 21.81 128.89 105.81 21.81 504.22 521.34 -3.28
Other Income 0.34 0.38 -10.53 0.34 0.38 -10.53 4.51 6.20 -27.26
PBIDT -21.63 -25.82 -16.23 -21.63 -25.82 -16.23 -82.72 -151.59 -45.43
Interest 13.18 10.97 20.15 13.18 10.97 20.15 46.89 29.73 57.72
PBDT -34.81 -36.79 -5.38 -34.81 -36.79 -5.38 -129.61 -181.32 -28.52
Depreciation 16.90 16.53 2.24 16.90 16.53 2.24 67.66 65.59 3.16
PBT -51.71 -53.32 -3.02 -51.71 -53.32 -3.02 -197.27 -246.91 -20.10
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -51.71 -53.32 -3.02 -51.71 -53.32 -3.02 -197.27 -246.91 -20.10
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -16.78 -24.40 -31.23 -16.78 -24.40 -31.23 -16.41 -29.08 -43.58

Krebs Biochem.&Inds Share Price

82.72 0.11 (0.13%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.